These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25112609)

  • 1. Efficacy and safety of dipeptidyl peptidase-4 inhibitors as an add-on to insulin treatment in patients with Type 2 diabetes: a review.
    Frandsen CS; Madsbad S
    Diabet Med; 2014 Nov; 31(11):1293-300. PubMed ID: 25112609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis of 11 Heterogeneous Studies regarding Dipeptidyl Peptidase 4 Inhibitor Add-On Therapy for Type 2 Diabetes Mellitus Patients Treated with Insulin.
    Shibuki K; Shimada S; Aoyama T
    J Diabetes Res; 2020; 2020():6321826. PubMed ID: 33224988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in black/African American patients with type 2 diabetes: Pooled analysis from eight Phase III trials.
    Thrasher J; Kountz DS; Crowe S; Woerle HJ; von Eynatten M
    Postgrad Med; 2015 Jun; 127(5):419-28. PubMed ID: 25840727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of subjects with type 2 diabetes enrolled in randomized controlled trials and non-randomized controlled trials in Japan: A systematic review.
    Kadowaki T; Shoji A; Taguchi Y
    J Diabetes Investig; 2023 Feb; 14(2):236-246. PubMed ID: 35726690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Kamrul-Hasan ABM; Alam MS; Talukder SK; Dutta D; Selim S
    Endocrinol Metab (Seoul); 2024 Feb; 39(1):109-126. PubMed ID: 38417828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease.
    Bittle PA
    Nurse Pract; 2017 Jun; 42(6):31-38. PubMed ID: 28225432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Yang J; Tian Q; Tang Y; Shah AK; Zhang R; Chen G; Zhang Y; Rajpathak S; Hong T
    Diabetes Ther; 2020 Oct; 11(10):2371-2382. PubMed ID: 32876863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis.
    Kamrul-Hasan ABM; Dutta D; Nagendra L; Sharma M; Patra S; Bhattacharya S
    Medicine (Baltimore); 2024 Jul; 103(28):e38870. PubMed ID: 38996148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study.
    Tse G; Lee S; Liu T; Zhou J
    Cardiovasc Drugs Ther; 2024 Apr; 38(2):391-392. PubMed ID: 38244149
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes in a Patient with Glycogen Storage Disease Type 1a.
    Kanemaru Y; Harada N; Wada N; Yasuda T; Okamura E; Fujii T; Ogura M; Inagaki N
    Intern Med; 2024 Aug; 63(15):2153-2156. PubMed ID: 38171878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl Peptidase-4 Inhibitors and the Risk of Chronic Inflammatory Skin Diseases in Type 2 Diabetes Mellitus in Taiwan: A Nationwide Population-Based Cohort Study.
    Chiu HY; Lin YJ; Huang YH
    J Invest Dermatol; 2024 Oct; 144(10):2321-2324.e5. PubMed ID: 38537930
    [No Abstract]   [Full Text] [Related]  

  • 12. A dipeptidyl peptidase-4 inhibitor for adults with type 2 diabetes.
    P T; 2010 Feb; 35(2):2-4. PubMed ID: 20221324
    [No Abstract]   [Full Text] [Related]  

  • 13. Much More Than Just Diabetes: The Pivotal Role of Dipeptidyl-Peptidase 4 in Skin Fibrosis.
    Vorstandlechner V; Mildner M
    J Invest Dermatol; 2024 Jun; ():. PubMed ID: 38842990
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it Time for Trials on Preventing Immune-Mediated Myocardial Damage?
    Peyster EG; Margulies KB
    JACC Basic Transl Sci; 2021 Jun; 6(6):543-545. PubMed ID: 34222725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPP-4 inhibitors: pharmacological differences and their clinical implications.
    Ceriello A; Sportiello L; Rafaniello C; Rossi F
    Expert Opin Drug Saf; 2014 Sep; 13 Suppl 1():S57-68. PubMed ID: 25171159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.
    Scheen AJ
    Expert Opin Drug Saf; 2015 Apr; 14(4):505-24. PubMed ID: 25630605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden.
    Kiadaliri AA; Gerdtham UG; Eliasson B; Carlsson KS
    Diabetes Ther; 2014 Dec; 5(2):591-607. PubMed ID: 25213800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of liraglutide on endothelial function in patients with type 2 diabetes.
    Nandy D; Johnson C; Basu R; Joyner M; Brett J; Svendsen CB; Basu A
    Diab Vasc Dis Res; 2014 Nov; 11(6):419-30. PubMed ID: 25212693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase.
    Kaku K; Mori M; Kanoo T; Katou M; Seino Y
    Expert Opin Pharmacother; 2014 Oct; 15(15):2121-30. PubMed ID: 25190226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiosyncratic liver injury induced by vildagliptin with successful switch to linagliptin in a hemodialyzed diabetic patient.
    Kurita N; Ito T; Shimizu S; Hirata T; Uchihara H
    Diabetes Care; 2014 Sep; 37(9):e198-9. PubMed ID: 25147262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.